Trinity Biotech (TRIB) Long-Term Investments (2017 - 2024)
Trinity Biotech (TRIB) has disclosed Long-Term Investments for 4 consecutive years, with $2.5 million as the latest value for Q4 2024.
- Quarterly Long-Term Investments changed N/A to $2.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2024, changed N/A year-over-year, with the annual reading at $2.5 million for FY2024, N/A changed from the prior year.
- Long-Term Investments hit $2.5 million in Q4 2024 for Trinity Biotech, up from $128000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.5 million in Q4 2024 to a low of $128000.0 in Q4 2022.
- Historically, Long-Term Investments has averaged $911000.0 across 3 years, with a median of $150000.0 in 2020.